Chiropractors in Lavallette, NJ Accepting Medicare
3 Chiropractors found. Showing 1 - 3
 Richard Nicholas Cattafi, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 100 West Kingfisher Way., Lavallette, NJ 08735 Phone: 732-618-0495 |
 Enright Chiropractic, L.l.c. Chiropractor - Sports Physician Medicare: Medicare Enrolled Practice Location: 907 Grand Central Ave, Lavallette, NJ 08735 Phone: 732-830-8400 Fax: 732-830-8499 |
Dr. James Joseph Enright Sr., D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 907 Grand Central Ave, Lavallette, NJ 08735 Phone: 732-830-8400 Fax: 732-830-8499 |
News Archive
Ischemic-targeted approach to angioplasty among asymptomatic survivors of heart attack
When compared with intensive drug therapy, percutaneous coronary intervention (PCI, angioplasty) was more beneficial in reducing the long-term risk of major cardiac events among heart attack survivors with "silent ischemia", according to a study in the May 9 issue of Journal of the American Medical Association.
SMA Foundation completes biomarker study for Spinal Muscular Atrophy
The Spinal Muscular Atrophy (SMA) Foundation, a nonprofit organization dedicated to accelerating the development of a treatment for SMA, is pleased to announce the completion of a pilot study to identify Biomarkers for Spinal Muscular Atrophy (BforSMA) and the discovery of over 400 candidate biomarkers.
Parabon launches Compute Against Alzheimer's Disease research initiative
Parabon Computation announced today the launch of the Compute Against Alzheimer's Disease (CAAD) research initiative, which will accelerate investigations into the causes and risks of Alzheimer's Disease (AD) through the application of large-scale computational capacity donated by concerned citizens and organizations.
AstraZeneca signs definitive agreement to acquire Novexel
Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial drug resistance, announces today that its shareholders have signed a definitive agreement whereby Novexel shall be acquired by AstraZeneca for a total cash consideration of up to $505 million, including contingent payments and the net cash position of the company at closing.
› Verified 1 days ago